Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRAX-628 in Adults With Focal Seizures
NCT06999902Phase 3Completed
- Sponsor
- Praxis Precision Medicines
- Start
- Dec 2024
- Primary completion
- May 2026
- Modality
- Classical Binding Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of vormatrigine in focal seizure, sponsored by Praxis Precision Medicines. Started Dec 2024; status: completed.
02
Drugs
vormatrigine
03
Conditions
focal seizure
Beyond the preview
Go deeper on NCT06999902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06999902.